-
Mashup Score: 2Blockchain Technology in Healthcare Market Size Projected to Reach USD 595.31 Billion by 2032 with 63.5% CAGR – SNS Insider - 7 day(s) ago
Blockchain technology in healthcare market is poised for exponential growth, driven by increasing demand for secure data management, streamlined…
Source: www.globenewswire.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 2
HEALWELL AI has entered into an agreement to acquire 100% of the shares of Auckland, New Zealand based Orion Health Holdings Limited (“Orion Health”), a…
Source: www.globenewswire.comCategories: General Medicine News, General HCPsTweet-
.@HEALWELL_AI to Acquire @OrionHealth, Creating a Global Market Leader in #Healthcare Data #Interoperability & #AI, and Launches $50 Million Bought Deal Financing | #MnA https://t.co/TJ3QusKXz6
-
-
Mashup Score: 26NCCN Guidelines Updated to Include ctDNA-MRD Testing Recommendation for B-Cell Lymphoma - 20 day(s) ago
BOULDER, Colo., Jan. 10, 2025 (GLOBE NEWSWIRE) — Foresight Diagnostics, a leader in ultra-sensitive minimal residual disease (MRD) detection technology,…
Source: www.globenewswire.comCategories: General Medicine News, Hem/OncsTweet-
🔈🔉🔊 #Hematology @NCCN Guidelines Updated to Include ctDNA-MRD Testing Recommendation for B-Cell #Lymphoma #lymsm #liquidbiopsy https://t.co/aA4LUU5nR7
-
-
Mashup Score: 26NCCN Guidelines Updated to Include ctDNA-MRD Testing Recommendation for B-Cell Lymphoma - 20 day(s) ago
BOULDER, Colo., Jan. 10, 2025 (GLOBE NEWSWIRE) — Foresight Diagnostics, a leader in ultra-sensitive minimal residual disease (MRD) detection technology,…
Source: www.globenewswire.comCategories: General Medicine News, Hem/OncsTweet-
🔈🔉🔊 #Hematology @NCCN Guidelines Updated to Include ctDNA-MRD Testing Recommendation for B-Cell #Lymphoma #lymsm #liquidbiopsy https://t.co/aA4LUU5nR7
-
-
Mashup Score: 26NCCN Guidelines Updated to Include ctDNA-MRD Testing Recommendation for B-Cell Lymphoma - 20 day(s) ago
BOULDER, Colo., Jan. 10, 2025 (GLOBE NEWSWIRE) — Foresight Diagnostics, a leader in ultra-sensitive minimal residual disease (MRD) detection technology,…
Source: www.globenewswire.comCategories: General Medicine News, Hem/OncsTweet-
🔈🔉🔊 #Hematology @NCCN Guidelines Updated to Include ctDNA-MRD Testing Recommendation for B-Cell #Lymphoma #lymsm #liquidbiopsy https://t.co/aA4LUU5nR7
-
-
Mashup Score: 12
Paris, France and Munich, Germany, January 09, 2025 – TRiCares SAS (“TRiCares”), a company pioneering a minimally-invasive tricuspid valve that flexes…
Source: www.globenewswire.comCategories: General Medicine News, CardiologistsTweet-
Topaz ….. user friendly, easy to use device, raises the bar for all TTVRs! Thanks to TRiCares for allowing us to be part of EFS! Look forward to gathering data for EFS and beyond! https://t.co/4NoePEildW
-
-
Mashup Score: 0
Paris, France and Munich, Germany, January 09, 2025 – TRiCares SAS (“TRiCares”), a company pioneering a minimally-invasive tricuspid valve that flexes…
Source: www.globenewswire.comCategories: General Medicine News, CardiologistsTweet-
Topaz ….. user friendly, easy to use device, raises the bar for all TTVRs! Thanks to TRiCares for allowing us to be part of EFS! Look forward to gathering data for EFS and beyond! https://t.co/4NoePEildW
-
-
Mashup Score: 0The Global Women's Digital Health Market to Surpass USD 25 Billion by 2035 with a CAGR of 20.56% - 23 day(s) ago
Dublin, Jan. 07, 2025 (GLOBE NEWSWIRE) — The
Source: www.globenewswire.comCategories: General Medicine News, General HCPsTweet-
Global Women’s Digital Health https://t.co/EDbHyOTYhO
-
-
Mashup Score: 9CES 2025 Hat Trick: FRENZ Brainband Secures 3rd CES Innovation Awards, Launching Focus Feature for Daily Life - 25 day(s) ago
The Consumer Technology Association (CTA) honors Earable® Neuroscience with a CES 2025 Innovation Awards® in Digital Health, marking its third consecutive…
Source: www.globenewswire.comCategories: General Medicine News, General HCPsTweet-
#CES2025 Hat Trick: FRENZ Brainband Secures 3rd CES Innovation Awards, Launching Focus Feature for Daily Life https://t.co/BDLpWg2vFU https://t.co/iflY7wpVsr
-
-
Mashup Score: 3Nurix Therapeutics Receives U.S. FDA Fast Track Designation for NX-5948 for the Treatment of Relapsed or Refractory Waldenstrom’s Macroglobulinemia - 1 month(s) ago
Fast track designation follows positive Phase 1 data presented at the 12th International Workshop on Waldenstrom’s Macroglobulinemia…
Source: www.globenewswire.comCategories: General Medicine News, Oncologists1Tweet-
🚨NEWS 🚨 @US_FDA grants fast track designation to NX-5948, a selective BTK degrader, for the treatment of adult patients with R/R #Waldenstrom’s macroglobulinemia after ≥2 lines of therapy, including a BTKi. Read more 👉 https://t.co/4VgRqNiLDV #lymphoma #lymsm #MedNews https://t.co/v6i3wpBHLT
-
Blockchain Technology in Healthcare Market Size Projected to Reach USD 595.31 Billion by 2032 with 63.5% CAGR https://t.co/Z0N5CZ1G8S